Bacitracin versus mupirocin for Staphylococcus aureus nasal colonization

Infection Control and Hospital Epidemiology

Volumn 20, Issue 5, 1999, Pages 351-353

  Soto, Norberto E ^a   Vaghjimal, Ashok ^a   Stahl Avicolli, Annette ^a   Protic, John R ^a   Lutwick, Larry I ^a   Chapnick, Edward K ^a  

^a MAIMONIDES MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BACITRACIN; PSEUDOMONIC ACID;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS INFECTION; DISEASE TRANSMISSION; DRUG EFFECT; FEMALE; HETEROZYGOTE; HUMAN; INFECTION CONTROL; MALE; METHODOLOGY; MICROBIOLOGY; NOSE MUCOSA; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TREATMENT OUTCOME;

ADULT; ANTI-BACTERIAL AGENTS; BACITRACIN; CARRIER STATE; CROSS INFECTION; DISEASE TRANSMISSION, PROFESSIONAL-TO-PATIENT; FEMALE; HUMANS; INFECTION CONTROL; MALE; MUPIROCIN; NASAL MUCOSA; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME;

EID: 0033124071     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/501633     Document Type: Article

References (10)

1. Doebbeling BN, Breneman DL, Neu HC, Aly R, Yangco BG, Holley HP Jr, et al Elimination of Staphylococcus aureus carriage in health care workers: analysis of six clinical trials with calcium mupirocin ointment. The Mupirocin Collaborative Study Group, Clin Infect Dis 1993;17:466-474.
2. Kluytmans JW, Manders MJ, vanBommel E, Verbrugh H. Elimination of nasal carriage of Staphylococcus aureus in hemodialysis patients. Infect Control Hosp Epidemiol 1996;17:793-797.
3. Kluytmans JW, Mouton JW, VandenBergh MFQ, Manders M-JAAJ, Maat APWM, Wagenvoort JHT, et al. Reduction of surgical-site infections in cardiothoracic surgery by elimination of nasal carriage of Staphylococcus aureus. Infect Control Hosp Epidemiol 1996;17:780-785.
4. Raz R, Mirn D, Colodner R, Staler Z, Samar Z, Keneess Y. A 1-year trial in the prevention of recurrent staphylococcal nasal colonization and skin infection. Arch Intern Med 1996;156:1109-1112.
5. Miller MA, Dascal A, Portnoy J, Mendelson J. Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment. Infect Control Hosp Epidemiol 1996;17:811-813.
6. Mapple PAC, Hamilton-Miller JMT, Brumfitt W. World-wide antibiotic resistance in methicillin-resistant Staphylococcus aureus. Lancet 1989;i:537-540.
7. Chapnick EK, Gradon JD, Kreiswirth B, Lutwick LI, Schaffer BC, Schiano TD, et al. Comparative killing kinetics of methicillin-resistant Staphylococcus aureus by bacitracin or mupirocin. Infect Control Hosp Epidemiol 1996;17:178-180.
8. Bryan CS, Wilson RS, Meade P, Sill LG. Topical antibiotic ointments for staphylococcal nasal carriers: survey of current practices and comparison of bacitracin and vancomycin ointments. Infect Control 1980;1:153-156.
9. Roccaforte JF, Bittner MJ, Stumpf CA, Prehelm LC. Attempts to eradicate methicillin-resistant Staphylococcus aureus colonization with the use of trimethoprim-sulfamethoxazole, rifampin, and bacitracin. Am J Infect Control 1988;16:141-146.
10. Mulligan ME, Murray-Leisure KA, Standiford HC, et al. Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management Am J Med 1993;94:313-328.